This would generate a self-amplifying cycle of epigenetic events leading to the long-term transcriptional repression of SHP and other tumor suppressors, which leads to increase of cell proliferation through the activation of Cyclin D1 and defective apoptosis through the loss of inhibition on antiapoptotic protein BCL2. The gene discussed is NR0B2; the disease is neoplasm.